Mark Meyer is a Cardiology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
635 Madison Ave Ste 1401
New York, NY 100221009
Telephone
212-583-2999Provider last certified this registry record 2 Jan 2020.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20253 payments
- Amgen Inc.Program year20252 payments
- Amgen Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.6%Statin19.8%Rosuvastatin Calcium57%Atorvastatin Calcium38%Simvastatin5%Part D<11 patientsAngiotensin receptor blocker (ARB)15%Valsartan45%Olmesartan Medoxomil28%Losartan Potassium17%Irbesartan5%Losartan-Hydrochlorothiazide5%Part D<11 patients+ 17 more classes in this area
Metabolism & gastrointestinal
9.3%SGLT2 inhibitor5.1%Jardiance100%Part D≥22 patientsBiguanide (metformin)2.2%Metformin Hcl100%Part D≥13 patients+ 2 more classes in this area
Blood & clotting
7.5%Factor Xa inhibitor6%Eliquis100%Part D≥28 patientsP2Y12 inhibitor1.5%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”